Literature DB >> 10498842

Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices.

A Siniscalchi1, D Rodi, L Beani, C Bianchi.   

Abstract

1. The effect of nociceptin (NC) on 5-hydroxytryptamine (5-HT) release was studied in rat cerebral cortex slices preincubated with [3H]-5-HT and electrically stimulated (3 Hz, for 2 min) at the 45th (St1) and the 75th (St2) min of superfusion. 2. NC (0.1 - 3 microM), present in the medium from the 70th min onward, concentration-dependently reduced electrically evoked [3H]-5-HT efflux (pEC50=6.54, Emax -54%). The inhibition was not antagonized by naloxone (1 microM) ruling out the involvement of opioid receptors. 3. Phe1psi(CH2-NH2)Gly2]NC(1-13)NH2, which acts as an opioid-like receptor (ORL1) antagonist at the peripheral level, behaved as a partial agonist in cerebral cortex slices i.e. it inhibited [3H]-5-HT efflux when added before St2, however, when present in the medium throughout the whole experiment, [Phe1psi(CH2-NH2)Gly2]NC(1-13)NH2 prevented the action of NC added at the 70th min. 4. The non-selective ORL1 receptor antagonist, naloxone benzoylhydrazone (3 microM), in the presence of 10 microM naloxone, did not modify the St2/St1 ratio but completely abolished the NC effect. 5. These findings demonstrate that NC inhibits 5-HT release from rat cerebral cortex slices via ORL1 receptors, suggesting its involvement in central processes mediated by 5-HT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498842      PMCID: PMC1571622          DOI: 10.1038/sj.bjp.0702793

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices.

Authors:  B Nicol; D G Lambert; D J Rowbotham; D Smart; A T McKnight
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  The orphanin FQ system: an emerging target for the management of pain?

Authors:  T Darland; D K Grandy
Journal:  Br J Anaesth       Date:  1998-07       Impact factor: 9.166

3.  Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.

Authors:  R Guerrini; G Calo; A Rizzi; C Bianchi; L H Lazarus; S Salvadori; P A Temussi; D Regoli
Journal:  J Med Chem       Date:  1997-06-06       Impact factor: 7.446

Review 4.  The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ.

Authors:  G Henderson; A T McKnight
Journal:  Trends Pharmacol Sci       Date:  1997-08       Impact factor: 14.819

5.  A new selective antagonist of the nociceptin receptor.

Authors:  R Guerrini; G Calo; A Rizzi; R Bigoni; C Bianchi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  1998-01       Impact factor: 8.739

6.  Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15.

Authors:  J L Montiel; F Cornille; B P Roques; F Noble
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

Review 7.  Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.

Authors:  J C Meunier
Journal:  Eur J Pharmacol       Date:  1997-12-04       Impact factor: 4.432

8.  Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.

Authors:  R Bigoni; S Giuliani; G Calo'; A Rizzi; R Guerrini; S Salvadori; D Regoli; C A Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-03       Impact factor: 3.000

9.  Nociceptin receptor-mediated Ca2+ channel inhibition and its desensitization in NG108-15 cells.

Authors:  H Morikawa; K Fukuda; H Mima; T Shoda; S Kato; K Mori
Journal:  Eur J Pharmacol       Date:  1998-06-19       Impact factor: 4.432

10.  Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites.

Authors:  J R Nicholson; S J Paterson; J R Menzies; A D Corbett; A T McKnight
Journal:  Can J Physiol Pharmacol       Date:  1998-03       Impact factor: 2.273

View more
  16 in total

1.  Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.

Authors:  K Flau; A Redmer; S Liedtke; M Kathmann; E Schlicker
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 2.  Nociceptin and the nociceptin receptor in learning and memory.

Authors:  Raül Andero
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-24       Impact factor: 5.067

3.  Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.

Authors:  Benjamin Berger; Anna Katharina Rothmaier; Franziska Wedekind; Josef Zentner; Thomas J Feuerstein; Rolf Jackisch
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 4.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.

Authors:  S Sbrenna; M Marti; M Morari; G Calo'; R Guerrini; L Beani; C Bianchi
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

6.  Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro.

Authors:  Anna Siniscalchi; Donata Rodi; Michele Morari; Matteo Marti; Sabrina Cavallini; Silvia Marino; Lorenzo Beani; Clementina Bianchi
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

Review 7.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

8.  Kainic acid down-regulates NOP receptor density and gene expression in human neuroblastoma SH-SY5Y cells.

Authors:  Rosalia Cannarsa; Daniela Landuzzi; Chiara Cavina; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2008-02-20       Impact factor: 3.444

Review 9.  Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.

Authors:  Elaine C Gavioli; Girolamo Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-21       Impact factor: 3.000

10.  Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor.

Authors:  Cristiano Nazzaro; Mario Barbieri; Katia Varani; Lorenzo Beani; Rita J Valentino; Anna Siniscalchi
Journal:  Neuropharmacology       Date:  2009-09-09       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.